levonorgestrel has been researched along with Adenocarcinoma in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (4.55) | 18.2507 |
| 2000's | 8 (36.36) | 29.6817 |
| 2010's | 11 (50.00) | 24.3611 |
| 2020's | 2 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Koskas, M; Maumy, L; Peigné, M | 1 |
| Hickey, M; Romero, SA; Su, HI; Young, K | 1 |
| Jun, HS; Kim, MK; Kim, ML; Lee, GH; Lee, YH; Seong, SJ; Song, T; Yoon, BS | 1 |
| Armes, J; Brennan, D; Gebski, V; Hawkes, AL; Janda, M; Obermair, A; Quinn, M | 1 |
| Grénman, S; Hurskainen, R; Mäenpää, J; Paavonen, J; Pukkala, E; Soini, T | 1 |
| Jóźwik, M; Modzelewska, B; Niewińska, M | 1 |
| Chin, J; Dominick, S; Hickey, M; Su, HI | 1 |
| Cetinkaya, N; Erkaya, S; Gungor, T; Yalcin, H; Zergeroglu, S | 1 |
| Bae, HS; Jung, YW; Kim, DH; Kim, M; Kim, MK; Seong, SJ; Shim, JY; Yun, BS | 1 |
| Chin, J; Hickey, M; Konje, JC | 1 |
| Leslie, KK; Thiel, KW; Yang, S | 1 |
| Broaddus, RR; Brown, AJ; Schmeler, K; Westin, SN | 1 |
| Ionouchene, SV; Pashov, AI; Tskhay, VB | 1 |
| Atkins, KA; Hanley, KZ; Mentrikoski, MJ; Shah, AA | 1 |
| Georgiou, M; Hyatt, D; Jones, K; Spencer, T; Thomas, H | 1 |
| Nwosu, EC; Sinha, A | 1 |
| Bahamondes, L; de Andrade, KC; Leon-Martins, O; Petta, CA; Ribeiro-Huguet, P | 1 |
| Archer, DF; Leslie, S; Mirkin, S; Navarro, FJ | 1 |
| Husemeyer, RP; Ndumbe, FM | 1 |
| Boutet, G | 1 |
| Kresowik, J; Ryan, GL; Van Voorhis, BJ | 1 |
| Joosten, JW; Kloosterboer, HJ; Schoonen, WG | 1 |
6 review(s) available for levonorgestrel and Adenocarcinoma
| Article | Year |
|---|---|
Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
Topics: Adenocarcinoma; Antineoplastic Agents, Hormonal; Breast Neoplasms; Chemotherapy, Adjuvant; Confidence Intervals; Contraceptive Agents, Female; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Neoplasm Recurrence, Local; Polyps; Randomized Controlled Trials as Topic; Tamoxifen; Uterine Hemorrhage; Uterus | 2020 |
[Levonorgestrel-releasing intrauterine system Mirena® (Bayer) for the prevention and treatment of endometrial adenocarcinoma and the incidence of other malignancies in women].
Topics: Adenocarcinoma; Carcinoma, Endometrioid; Contraceptive Agents, Female; Endometrial Hyperplasia; Endometrial Neoplasms; Evidence-Based Medicine; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel | 2015 |
Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
Topics: Adenocarcinoma; Antineoplastic Agents, Hormonal; Breast Neoplasms; Chemotherapy, Adjuvant; Contraceptive Agents, Female; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Neoplasm Recurrence, Local; Polyps; Randomized Controlled Trials as Topic; Tamoxifen | 2015 |
Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
Topics: Adenocarcinoma; Antineoplastic Agents, Hormonal; Breast Neoplasms; Chemotherapy, Adjuvant; Contraceptive Agents, Female; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Neoplasm Recurrence, Local; Polyps; Randomized Controlled Trials as Topic; Tamoxifen | 2009 |
Endometrial polyp and the levonorgestrel intrauterine system--a case report and literature review.
Topics: Adenocarcinoma; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Polyps; Progesterone Congeners | 2002 |
[Levonorgestrel-releasing intrauterine device (Mirena) and breast cancer: what do we learn from literature for clinical practice?].
Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Hormonal; Breast Neoplasms; Contraceptive Agents, Female; Endometrial Neoplasms; Evidence-Based Medicine; Female; France; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Tamoxifen | 2006 |
2 trial(s) available for levonorgestrel and Adenocarcinoma
| Article | Year |
|---|---|
Improving treatment for obese women with early stage cancer of the uterus: rationale and design of the levonorgestrel intrauterine device ± metformin ± weight loss in endometrial cancer (feMME) trial.
Topics: Adenocarcinoma; Biomarkers, Tumor; Diet; Endometrial Neoplasms; Exercise; Female; Humans; Intrauterine Devices; Levonorgestrel; Metformin; Neoplasm Staging; Obesity; Prospective Studies; Research Design; Weight Loss | 2014 |
The combined GnRH-agonist and intrauterine levonorgestrel-releasing system treatment of complicated atypical hyperplasia and endometrial cancer: a pilot study.
Topics: Adenocarcinoma; Administration, Intravaginal; Adult; Antineoplastic Agents, Hormonal; Delayed-Action Preparations; Drug Delivery Systems; Drug Therapy, Combination; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Gonadotropin-Releasing Hormone; Humans; Injections, Intramuscular; Leuprolide; Levonorgestrel; Neoplasm Staging; Organ Sparing Treatments; Pilot Projects; Progestins; Young Adult | 2012 |
14 other study(ies) available for levonorgestrel and Adenocarcinoma
| Article | Year |
|---|---|
A survey of French gynecologists' knowledge and attitudes toward conservative treatment for fertility preservation in young patients with endometrial cancer.
Topics: Adenocarcinoma; Adult; Attitude of Health Personnel; Conservative Treatment; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; France; Gonadotropin-Releasing Hormone; Gynecologic Surgical Procedures; Gynecology; Health Knowledge, Attitudes, Practice; Humans; Hysteroscopy; Intrauterine Devices, Medicated; Levonorgestrel; Male; Middle Aged; Patient Education as Topic; Pregnancy; Progestins; Reproductive Medicine; Surveys and Questionnaires | 2020 |
Comparison of dilatation & curettage and endometrial aspiration biopsy accuracy in patients treated with high-dose oral progestin plus levonorgestrel intrauterine system for early-stage endometrial cancer.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Fine-Needle; Dilatation and Curettage; Endometrial Neoplasms; Endometrium; Female; Fertility Preservation; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Neoplasm Staging; Organ Sparing Treatments; Progestins; Prospective Studies | 2013 |
Cancer risk in women using the levonorgestrel-releasing intrauterine system in Finland.
Topics: Adenocarcinoma; Adult; Breast Neoplasms; Contraceptive Agents, Female; Endometrial Neoplasms; Female; Finland; Follow-Up Studies; Humans; Incidence; Intrauterine Devices, Medicated; Levonorgestrel; Lung Neoplasms; Menorrhagia; Middle Aged; Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Registries | 2014 |
Clinicopathologic characteristics and treatment features of women with the incidental diagnosis of endometrial adenocarcinoma during infertility follow-up in Ankara, Turkey.
Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Hormonal; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Incidental Findings; Infertility, Female; Intrauterine Devices, Medicated; Levonorgestrel; Megestrol Acetate; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Pregnancy; Pregnancy Rate; Retrospective Studies; Turkey | 2016 |
Dilatation and curettage is more accurate than endometrial aspiration biopsy in early-stage endometrial cancer patients treated with high dose oral progestin and levonorgestrel intrauterine system.
Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Hormonal; Biopsy, Needle; Dilatation and Curettage; Endometrial Neoplasms; Endometrium; Female; Fertility Preservation; Humans; Intrauterine Devices; Levonorgestrel; Medroxyprogesterone Acetate; Progestins; Prospective Studies; Reproducibility of Results | 2017 |
Endometrial cancer: potential treatment and prevention with progestin-containing intrauterine devices.
Topics: Adenocarcinoma; Contraceptive Agents, Female; Endometrial Neoplasms; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel | 2012 |
Progestin intrauterine device in an adolescent with grade 2 endometrial cancer.
Topics: Adenocarcinoma; Adolescent; Contraceptive Agents, Female; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Organ Sparing Treatments | 2012 |
Assessing endometrial hyperplasia and carcinoma treated with progestin therapy.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antineoplastic Agents, Hormonal; Cohort Studies; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Female; Humans; Levonorgestrel; Megestrol Acetate; Menopause; Middle Aged; Prognosis; Treatment Failure; Young Adult | 2012 |
Endometrial adenocarcinoma following the insertion of a Mirena IUCD.
Topics: Adenocarcinoma; Endometrial Neoplasms; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged | 2002 |
Levonorgestrel-releasing intrauterine system (Mirena) as a therapy for endometrial hyperplasia and carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Delayed-Action Preparations; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Levonorgestrel; Middle Aged; Progesterone Congeners; Treatment Outcome | 2003 |
Effects of levonorgestrel, medroxyprogesterone acetate, norethindrone, and 17beta-estradiol on vascular endothelial growth factor isomers 121 and 165 in Ishikawa cells.
Topics: Adenocarcinoma; Endometrial Neoplasms; Endometrium; Estradiol; Female; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Norethindrone; Prospective Studies; Protein Isoforms; Receptors, Progesterone; RNA, Messenger; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A | 2004 |
Endometrial adenocarcinoma in association with a levonorgestrel-releasing intrauterine system (Mirena).
Topics: Adenocarcinoma; Contraceptive Agents, Female; Endometrial Neoplasms; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged | 2006 |
Progression of atypical endometrial hyperplasia to adenocarcinoma despite intrauterine progesterone treatment with the levonorgestrel-releasing intrauterine system.
Topics: Adenocarcinoma; Adult; Contraceptive Agents, Female; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Treatment Failure | 2008 |
Effects of two classes of progestagens, pregnane and 19-nortestosterone derivatives, on cell growth of human breast tumor cells: I. MCF-7 cell lines.
Topics: Adenocarcinoma; Breast Neoplasms; Cell Division; Desogestrel; Estradiol; Estrogen Antagonists; Female; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Models, Statistical; Nandrolone; Norethindrone; Norpregnenes; Pregnanes; Pregnenediones; Progesterone; Promegestone; Receptors, Androgen; Receptors, Estrogen; Receptors, Progesterone; Tumor Cells, Cultured | 1995 |